SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

TwinStrand Biosciences Says USPTO Confirms Patentability of Core Sequencing Patent

The company says all 23 claims of the exclusively licensed ’631 patent remain intact after an unappealed USPTO decision.

GH

Related stories